Aurobindo Pharma Buyback 2026 vs Jagsonpal Pharmaceuticals Buyback 2026

Note:

• Small Shareholders are retail shareholders under SEBI regulations.

• General Category includes all other eligible shareholders.

• Entitlement ratio is based on fully paid-up equity shares held on the record date.

Note:

• Small Shareholders are retail shareholders under SEBI regulations.

• General Category includes all other eligible shareholders.

• Entitlement ratio is based on fully paid-up equity shares held on the record date.

The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:

• Return surplus funds to shareholders and enhance overall shareholder returns.
• Optimise the Company’s capital structure.
• Improve financial ratios such as earnings per share and return on equity.
• Enhance long-term shareholder value.
• Provide shareholders the flexibility to either participate in the Buyback for cash or retain their shareholding and benefit from an increased post-buyback ownership.

The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:

• Return surplus funds to shareholders and enhance overall shareholder returns.
• Improve financial ratios such as earnings per share and return on equity.